PURPOSE: Sleep/wake disturbances are prevalent in patients with advanced cancer, but 24-hour polysomnography (PSG) examinations of these patterns have not been undertaken. The purpose of this study was to describe these sleep/wake patterns using continuous PSG and to explore relationships with selected demographic and clinical variables. PATIENTS AND METHODS: The sample included patients with advanced cancer (solid tumors); those with neurologic disorders or psychosis, substance abuse, or brain metastasis were excluded. The final sample included 114 participants with a mean age of 51.1 years (+/- 9.1 years). Participants underwent continuous, ambulatory PSG for 42 hours in their home environments. Standard PSG measures were calculated. Analysis included data from 2 nights and the intervening day. Descriptive statistics were used to summarize sleep/wake parameters of the average of the 2 nights and the intervening day. Nonparametric analyses were used to detect differences and relationships among the variables. RESULTS: Compared with normative data, participants had reduced quantity and quality of nocturnal sleep and episodes of sleep scattered throughout the day. Increased daytime sleep was negatively associated with several key parameters of nocturnal sleep quantity and quality. Women, whites, and those who were married/partnered and had more education had better nocturnal sleep. Cancer type and selected medications may be risk factors for disturbed sleep and waking. CONCLUSION: Participants experienced severe difficulty with "state maintenance", or the ability to maintain both the sleep and waking states. Research designed to identify the etiology of these problems is needed to develop effective interventions.
PURPOSE: Sleep/wake disturbances are prevalent in patients with advanced cancer, but 24-hour polysomnography (PSG) examinations of these patterns have not been undertaken. The purpose of this study was to describe these sleep/wake patterns using continuous PSG and to explore relationships with selected demographic and clinical variables. PATIENTS AND METHODS: The sample included patients with advanced cancer (solid tumors); those with neurologic disorders or psychosis, substance abuse, or brain metastasis were excluded. The final sample included 114 participants with a mean age of 51.1 years (+/- 9.1 years). Participants underwent continuous, ambulatory PSG for 42 hours in their home environments. Standard PSG measures were calculated. Analysis included data from 2 nights and the intervening day. Descriptive statistics were used to summarize sleep/wake parameters of the average of the 2 nights and the intervening day. Nonparametric analyses were used to detect differences and relationships among the variables. RESULTS: Compared with normative data, participants had reduced quantity and quality of nocturnal sleep and episodes of sleep scattered throughout the day. Increased daytime sleep was negatively associated with several key parameters of nocturnal sleep quantity and quality. Women, whites, and those who were married/partnered and had more education had better nocturnal sleep. Cancer type and selected medications may be risk factors for disturbed sleep and waking. CONCLUSION:Participants experienced severe difficulty with "state maintenance", or the ability to maintain both the sleep and waking states. Research designed to identify the etiology of these problems is needed to develop effective interventions.
Authors: Christopher G Slatore; Elizabeth R Goy; Daniel J Oʼhearn; Eilis A Boudreau; Jean P OʼMalley; Dawn Peters; Linda Ganzini Journal: Am J Geriatr Psychiatry Date: 2012-04 Impact factor: 4.105
Authors: Joseph A Roscoe; Michael L Perlis; Wilfred R Pigeon; Kristen H O'Neill; Charles E Heckler; Sara E Matteson-Rusby; Oxana G Palesh; Michelle Shayne; Alissa Huston Journal: J Psychosom Res Date: 2011-09-22 Impact factor: 3.006
Authors: Lauren Clevenger; Andrew Schrepf; Koenraad Degeest; David Bender; Michael Goodheart; Amina Ahmed; Laila Dahmoush; Frank Penedo; Joseph Lucci; Premal H Thaker; Luis Mendez; Anil K Sood; George M Slavich; Susan K Lutgendorf Journal: Cancer Date: 2013-06-24 Impact factor: 6.860
Authors: Arianna Aldridge-Gerry; Jamie M Zeitzer; Oxana G Palesh; Booil Jo; Bita Nouriani; Eric Neri; David Spiegel Journal: Sleep Med Date: 2013-09-05 Impact factor: 3.492
Authors: Edward J Stepanski; Mark S Walker; Lee S Schwartzberg; L Johnetta Blakely; Jason C Ong; Arthur C Houts Journal: J Clin Sleep Med Date: 2009-04-15 Impact factor: 4.062
Authors: Pasquale F Innominato; Christian Focan; Thierry Gorlia; Thierry Moreau; Carlo Garufi; Jim Waterhouse; Sylvie Giacchetti; Bruno Coudert; Stefano Iacobelli; Dominique Genet; Marco Tampellini; Philippe Chollet; Marie-Ange Lentz; Marie-Christine Mormont; Francis Lévi; Georg A Bjarnason Journal: Cancer Res Date: 2009-06-01 Impact factor: 12.701
Authors: Pasquale F Innominato; Andrew S Lim; Oxana Palesh; Mark Clemons; Maureen Trudeau; Andrea Eisen; Cathy Wang; Alex Kiss; Kathleen I Pritchard; Georg A Bjarnason Journal: Support Care Cancer Date: 2015-08-11 Impact factor: 3.603